U.S. markets closed

Pharming Group N.V. (PHAR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
12.96-0.39 (-2.92%)
At close: 4:00PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
Total Revenue
179,680
169,022
135,130
89,620
Cost of Revenue
20,257
21,355
22,180
12,445
Gross Profit
159,423
147,667
112,950
77,175
Operating Expense
90,837
86,760
74,958
55,263
Operating Income
68,586
60,907
37,992
21,912
Net Non Operating Interest Income Expense
-14,989
-13,788
-35,493
-76,252
Pretax Income
53,913
46,679
857
-89,399
Tax Provision
13,169
10,484
-24,136
-9,442
Net Income Common Stockholders
40,744
36,195
24,993
-79,957
Diluted NI Available to Com Stockholders
40,744
36,195
24,993
-79,957
Basic EPS
-
0
0
-0.0016
Diluted EPS
-
0
0
-0.0016
Basic Average Shares
-
62,632
60,662
50,041
Diluted Average Shares
-
67,352
65,353
50,041
Total Operating Income as Reported
68,586
60,907
37,992
21,912
Total Expenses
111,094
108,115
97,138
67,708
Net Income from Continuing & Discontinued Operation
40,744
36,195
24,993
-79,957
Normalized Income
40,832
36,357
25,364
-43,928
Interest Income
1,023
1,011
18
3
Interest Expense
8,133
11,917
14,311
17,738
Net Interest Income
-14,989
-13,788
-35,493
-76,252
EBIT
62,046
58,596
15,168
-71,661
EBITDA
67,551
-
-
-
Reconciled Cost of Revenue
20,257
21,355
22,180
12,445
Reconciled Depreciation
5,505
5,177
6,559
3,415
Net Income from Continuing Operation Net Minority Interest
40,744
36,195
24,993
-79,957
Total Unusual Items Excluding Goodwill
-117
-209
-495
-40,284
Total Unusual Items
-117
-209
-495
-40,284
Normalized EBITDA
67,668
63,982
22,222
-27,962
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
-28.5789
-46.9409
-123.75
-4,255